Five Prime Therapeutics OverviewFive Prime Therapeutics Research & Development
Research & Development expenses for FPRX.
Quarterly R&D Expenses
$12.92M
↓ 50.2% YoY
As of Dec 31, 2020
Annual R&D Expenses (TTM)
$65.49M
↓ 42.58% YoY
Trailing 12 months ending Dec 31, 2020